Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mai-Britt Zocca Insider Profile
4 Followers
Mai-Britt Zocca, CEO, Director at IO Biotech, holds 76.47K shares in IO Biotech (Ticker: IOBT). Most recently, Mai-Britt Zocca Bought $12,500 shares of IO Biotech on Dec 23, 2024 for an estimated value of 10.00K.
Mai-Britt Zocca has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mai-Britt Zocca's holdings
Insider Roles
CEO, Director
Roles that Mai-Britt Zocca holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mai-Britt Zocca
Mai-Britt Zocca's Trading History
List of latest transactions for each holding click on a transaction to see Mai-Britt Zocca's performance on stock
You May Also Like
Mai-Britt Zocca insider profile FAQ
What is the percentage of profitable transactions made by Mai-Britt Zocca?
The percentage of profitable transactions made by Mai-Britt Zocca is ―.
What is the average return per transaction made by Mai-Britt Zocca?
The average return per transaction made by Mai-Britt Zocca is ―.
What stocks does Mai-Britt Zocca hold?
Mai-Britt Zocca holds: IOBT stocks.
What was Mai-Britt Zocca’s latest transaction?
Mai-Britt Zocca latest transaction was an Informative Buy of $10.00K.
What was Mai-Britt Zocca's most profitable transaction?
Mai-Britt Zocca’s most profitable transaction was an Informative Buy of IOBT stock on December 23, 2024. The return on the trade was 5.10%.
What is Mai-Britt Zocca's role in IO Biotech?
Mai-Britt Zocca's role in IO Biotech is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.